Form 4: Clover Health CEO Conrad Wai Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO of Clover Health, Conrad Wai, disposed of 24,470 shares of Class A Common Stock to cover tax obligations arising from the vesting of restricted stock units.
Summary
- On January 31, 2025, Conrad Wai, CEO of Counterpart Health and an officer of Clover Health Investments, disposed of 24,470 shares of Class A Common Stock.
- The shares were sold at a price of $4.39 per share.
- This transaction was to cover tax obligations related to the vesting of 12.5% of time-based restricted stock units (RSUs) granted on October 31, 2023.
- Following the transaction, Wai still beneficially owns 3,344,063 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations. It doesn't necessarily reflect a positive or negative sentiment towards the company's future prospects.
Future Outlook
The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when stock options or restricted stock units vest. The transaction itself doesn't necessarily indicate a change in the executive's confidence in the company.
Comparison to Industry Standards
- Executive compensation packages often include stock options and RSUs as a way to align management's interests with those of shareholders.
- The vesting schedules and tax implications of these equity grants are standard across the industry.
- Similar transactions are regularly reported by executives at other healthcare companies such as UnitedHealth Group (UNH), Humana (HUM), and CVS Health (CVS).
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations and does not represent a significant change in the executive's holdings.
Key Dates
| Date | Description |
|---|---|
| October 31, 2023 | Date of original grant of time-based restricted stock units (RSUs) to Conrad Wai. |
| November 2, 2023 | Date Form 4 was filed reporting the grant of RSUs. |
| January 31, 2025 | Date of transaction: Disposal of shares to cover tax obligations upon vesting of RSUs. |
| October 31, 2025 | Final vesting date of the remaining RSUs, subject to continued service. |
| February 04, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.